Insider · CIK 0001740730
Colleen F Reitan
director
Files at MYGN (MYRIAD GENETICS INC), ALNY (ALNYLAM PHARMACEUTICALS, INC.). First filing May 12, 2025, latest Sep 11, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 2
$10k bought, $8.4M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ALNY: ALNYLAM PHARMACEUTICALS, INC.
ALNYOct 9, 2026 · close 232.68
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | ALNYLAM PHARMACEUTICALS, INC. | $8.4M 18,000 shares | -96% | +115% from low0% from high | |
| 23Weak | ALNYbuy ALNYLAM PHARMACEUTICALS, INC. | $10k 36 shares | - | - | |
| 45Moderate | ALNYsell ALNYLAM PHARMACEUTICALS, INC. | $8,383 36 shares | -100% | +3% from low-23% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 9, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +18,000 | $100.65 | $1.8M | 18,775 | Sep 11, 2025 |
| Sep 9, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,645 | $457.44 | $752k | 17,130 | Sep 11, 2025 |
| Sep 9, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,888 | $458.86 | $866k | 15,242 | Sep 11, 2025 |
| Sep 9, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,403 | $459.73 | $645k | 13,839 | Sep 11, 2025 |
| Sep 9, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -473 | $460.71 | $218k | 13,366 | Sep 11, 2025 |
| Sep 9, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -2,290 | $461.92 | $1.1M | 11,076 | Sep 11, 2025 |
| Sep 9, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,652 | $463.00 | $765k | 9,424 | Sep 11, 2025 |
| Sep 9, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -799 | $464.36 | $371k | 8,625 | Sep 11, 2025 |
| Sep 9, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -222 | $471.25 | $105k | 8,403 | Sep 11, 2025 |
| Sep 9, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -823 | $472.82 | $389k | 7,580 | Sep 11, 2025 |
| Sep 9, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -838 | $474.22 | $397k | 6,742 | Sep 11, 2025 |
| Sep 9, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -951 | $474.85 | $452k | 5,791 | Sep 11, 2025 |
| Sep 9, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -972 | $476.31 | $463k | 4,819 | Sep 11, 2025 |
| Sep 9, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,183 | $477.47 | $565k | 3,636 | Sep 11, 2025 |
| Sep 9, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,450 | $478.67 | $694k | 2,186 | Sep 11, 2025 |
| Sep 9, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,386 | $479.55 | $665k | 800 | Sep 11, 2025 |
| Sep 9, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -25 | $480.98 | $12k | 775 | Sep 11, 2025 |
| Sep 9, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -18,000 | $0.00 | $0 | 0 | Sep 11, 2025 |
| Jun 5, 2025 | MYGN MYRIAD GENETICS INC | AGrant or award Common Stock | +49,796 | $0.00 | $0 | 92,329 | Jun 6, 2025 |
| Aug 29, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | POpen-market purchase Common Stock | +32 | $286.00 | $9,152 | 32 | May 12, 2025 |
| Oct 17, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | POpen-market purchase Common Stock | +4 | $302.67 | $1,211 | 36 | May 12, 2025 |
| Apr 16, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -36 | $232.86 | $8,383 | 0 | May 12, 2025 |
| May 8, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | AGrant or award Common Stock | +775 | $0.00 | $0 | 775 | May 12, 2025 |
| May 8, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | AGrant or award Stock Option (right to buy)derivative | +1,558 | $0.00 | $0 | 1,558 | May 12, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.